The Lead Episode 19: A Discussion of Early versus Later Anticoagulation for Stroke with Atrial Fibrillation

Discussion Topic: Early Versus Later Anticoagulation for Stroke with Atrial Fibrillation by U. Fischer et al.

Deepthy Varghese, MSN, FNP of Northside Hospital is joined by guests, Niraj Sharma, MD, FHRS, of Northside Hospital, and Kamala P. Tamirisa, of Texas Cardiac Arrhythmia to discuss early versus later anticoagulation for stroke with atrial fibrillation. In this trial, the incidence of recurrent ischemic stroke, systemic embolism, major extracranial bleeding, symptomatic intracranial hemorrhage, or vascular death at 30 days was estimated to range from 2.8 percentage points lower to 0.5 percentage points higher (based on the 95% confidence interval) with early than with later use of DOACs. (Funded by the Swiss National Science Foundation and others; ELAN ClinicalTrials.gov number, NCT03148457.)

Host: Deepthy Varghese, MSN, ACNP, FNP
Guests: Niraj Sharma, MD, FHRS and Kamala P. Tamirisa MD, FHRS

Speaker and Article Information: Download

• Listen on HRS365
• Listen on Apple Podcasts
• Listen on Spotify